Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Cardinal Health ( (CAH) ) is now available.
Cardinal Health reported a 4% decrease in second-quarter fiscal year 2025 revenues to $55.3 billion, though revenue increased by 16% when excluding a significant customer contract expiration. The company also announced a 9% increase in non-GAAP operating earnings to $635 million and raised its fiscal year 2025 non-GAAP EPS guidance. The acquisition of a 73% stake in GI Alliance was completed, aligning with strategic growth in specialty sectors.
More about Cardinal Health
Cardinal Health is a major player in the healthcare industry, primarily focusing on pharmaceutical and specialty solutions. The company is known for its comprehensive distribution of medical products and services, catering to a wide range of healthcare providers and facilities.
YTD Price Performance: 8.49%
Average Trading Volume: 2,264,473
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $30.91B
See more data about CAH stock on TipRanks’ Stock Analysis page.
